Gut microbiota depletion following ATB use reduces α-diversity and suppresses production of SCFAs (e.g., butyrate), leading to expanded Treg populations and impaired CD8+ T cell cytotoxicity in melanoma patients (278). This evidence concerns the gene CD8A and melanoma.